Related Experiment Video
Updated: May 18, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
PSMC1 Gene in Parkinson's Disease
Pilar Gómez-Garre1, Silvia Jesús, Fátima Carrillo
1Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
European Neurology
|September 6, 2012
Summary
Genetic variations in the PSMC1 gene were investigated for their link to Parkinson's disease (PD) susceptibility. This study found no association between PSMC1 gene variations and PD, suggesting it is not involved in the disease's development.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- The ubiquitin-proteasome system's impairment is implicated in Parkinson's disease (PD) pathogenesis.
- The PSMC1 gene encodes the 26S proteasome regulatory subunit 1.
- PSMC1 knockout mice exhibit a PD-like phenotype, prompting investigation into its role in human PD.
Purpose of the Study:
- To investigate the association between variations in the PSMC1 gene and susceptibility to Parkinson's disease.
- To analyze PSMC1 gene polymorphisms and haplotypes in PD patients and control subjects.
Main Methods:
- Genotyping of four PSMC1 polymorphisms using TaqMan assays in 283 PD patients and 316 controls.
- High-resolution melting analysis to identify novel variations in PSMC1 exons and exon-intron boundaries.
- Comparative analysis of minor allele frequencies between PD patients and control groups.
Main Results:
- No significant differences in minor allele frequencies of PSMC1 polymorphisms were observed between PD patients and control subjects.
- Sequence analysis of PSMC1 exons and exon-intron boundaries did not reveal any disease-associated variations.
- Haplotype analysis indicated no correlation between PSMC1 haplotypes and Parkinson's disease.
Conclusions:
- The PSMC1 gene and its variations are unlikely to be involved in the pathogenesis of Parkinson's disease.
- The study provides evidence against a direct role of PSMC1 genetic alterations in PD susceptibility.
- Further research may explore other genetic factors contributing to the ubiquitin-proteasome system's dysfunction in PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...